-
Real-world population pharmacokinetics of tezacaftor-ivacaftor in children with cystic fibrosis: The SYM-CF study
Vonk, S. E. M., Terheggen-Lagro, S. W. J., Haarman, E. G., Janssens, H. M., Maitland–van der Zee, A.-H. & Amsterdam Mucociliary Clearance Disease (AMCD) research group, Oct 2025, In: British Journal of Clinical Pharmacology. 91, 10, p. 2969-2978 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History
SysPharmPediA and U‐BIOPRED Consortia, 18 Aug 2025, (E-pub ahead of print) In: Allergy.Research output: Contribution to journal › Article › Academic › peer-review
-
Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation
Abdel-Aziz, M. I., Hashimoto, S., Neerincx, A. H., Haarman, E. G., Cecil, A., Lintelmann, J., Witting, M., Hauck, S. M., Kerssemakers, N., Verster, J. C., Bang, C., Franke, A., Dierdorp, B. S., Dekker, T., Metwally, N. K. A., Duitman, J. W., Lutter, R., Gorenjak, M., Toncheva, A. A. & Kheiroddin, P. & 10 others, , Aug 2025, In: Journal of Allergy and Clinical Immunology. 156, 2, p. 339-351 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
